Reduced obesity-associated abnormalities (hepatic steatosis)Increased leptin potencyImproved hepatic insulin sensitivityEnhanced glucose tolerance and glucose homeostasisReduction in pro-inflammatory cytokinesEnhanced lipid and glucose metabolism. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.